Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial

Published:2020-06-25 Issue: Volume:11 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Shah-Williams Ebony,Levy Kenneth D.,Zang Yong,Holmes Ann M.,Stoughton Christa,Dexter Paul,Skaar Todd C.

Funder

National Institutes of Health

Publisher

Frontiers Media SA

Subject

Genetics(clinical),Genetics,Molecular Medicine

Reference30 articles.

1. Evaluation of worldwide clinical trials by gender: an FDA perspective.;Ayuso;Contemp. Clin. Trials,2019

2. Idiosyncratic drug induced liver injury in african-americans is associated with greater morbidity and mortality compared to caucasians.;Chalasani;Am. J. Gastroenterol.,2017

3. Patient-centered recruitment and retention for a randomized controlled study.;Chhatre;Trials,2019

4. What is the key to culturally competent care: reducing bias or cultural tailoring?.;Cuevas;Psychol. Health,2017

5. Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.;Eadon;Clin. Pharmacol. Ther.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial;The Pharmacogenomics Journal;2023-09-09

2. Adapting a Research and Community Capacity-Building Program to Address Rural Cancer Burden and Facilitate Partnership Development Between Rural Community Stakeholders and an Urban Comprehensive Cancer Center;Journal of Cancer Education;2023-01-03

3. Toward representative genomic research: the children’s rare disease cohorts experience;Therapeutic Advances in Rare Disease;2023-01

4. Ethical Issues in Pharmacogenomics;Pharmacogenomics in Clinical Practice;2023

5. Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?;Cureus;2022-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3